Logotype for Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries (SUNPHARMA) investor relations material

Sun Pharmaceutical Industries Q1 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Sun Pharmaceutical Industries Limited
Q1 25/26 earnings summary31 Jul, 2025

Executive summary

  • Q1 FY26 sales reached INR 137,861 million, up 10.1% year-over-year, with strong growth in India and emerging markets, and continued momentum in innovative medicines.

  • EBITDA grew 19.2% year-over-year to INR 43,017 million, with margin at 31.1%, driven by favorable product mix and higher specialty sales.

  • Adjusted net profit rose 5.7% to INR 29,961 million; reported net profit was INR 22,786 million after exceptional items.

  • India formulation sales grew 13.9% year-over-year, outpacing the market, led by volume and new launches.

  • Global innovative medicines sales climbed 16.9% to $311 million, now 19.3% of total sales.

Financial highlights

  • Gross margin improved due to lower material costs and higher innovative medicines share.

  • Exceptional items of INR 8,180 million included SCD044 impairment and GSMDL settlement.

  • Forex gain of INR 2,290 million versus a loss last year; other income lower due to prior year tax refund.

  • Net cash position at $3.1 billion, invested in approved securities for future investments.

  • Adjusted EPS for the quarter was INR 12.5.

Outlook and guidance

  • Plan to file for ILUMYA psoriatic arthritis indication by year-end; expect U.S. launch of Unloxit in H2 FY26.

  • R&D spend guidance maintained; higher promotional expenses for new launches expected to be sustained through the year.

  • Effective tax rate expected around 25% for the full year.

  • Continued investment in R&D and pipeline development, with six novel entities in clinical stage.

  • Management highlighted strong performance and steady progress across all markets, with India and US launches driving growth.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Sun Pharmaceutical Industries earnings date

Logotype for Sun Pharmaceutical Industries Limited
Q2 25/2631 Oct, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Sun Pharmaceutical Industries earnings date

Logotype for Sun Pharmaceutical Industries Limited
Q2 25/2631 Oct, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Sun Pharmaceutical Industries Limited operates as a pharmaceutical company. It manufactures, develops and markets generic pharmaceutical products, active pharmaceutical ingredients and intermediates, and formulation products for various dosage forms.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage